Literature DB >> 17192604

How three-finger-fold toxins interact with various cholinergic receptors.

Carole Fruchart-Gaillard1, Gilles Mourier, Catherine Marquer, André Ménez, Denis Servent.   

Abstract

Three-finger-fold toxins, isolated from various snake venoms, are recognized by high affinity and various specificities by different nicotinic and muscarinic acetylcholine receptors (nAChRs and mAChRs, respectively) present in peripheral, as well as central, nervous systems (Karlsson et al., 2000; Servent and Ménez, 2001; Nirthanan and Gwee, 2004). The goal of our studies is (1) to identify, at the molecular level, the functional determinants involved in the various interaction profiles of nicotinic or muscarinic toxins on their respective receptors subtypes, (2) to model some of these toxin-receptor complexes using distance constraints obtained from cycle-mutant experiments, and (3) to understand how a unique scaffold (the three-finger fold) is able to support these different functional profiles and how molecular determinants have been selected during the evolution process to create these different specific properties. Finally, these structure/function analyses should be exploited to engineer non-natural peptides with new binding and functional properties useful as pharmacological tools or therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192604     DOI: 10.1385/JMN:30:1:7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  8 in total

1.  Variability among the sites by which curaremimetic toxins bind to torpedo acetylcholine receptor, as revealed by identification of the functional residues of alpha-cobratoxin.

Authors:  S Antil; D Servent; A Ménez
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  Molecular determinants by which a long chain toxin from snake venom interacts with the neuronal alpha 7-nicotinic acetylcholine receptor.

Authors:  S Antil-Delbeke; C Gaillard; T Tamiya; P J Corringer; J P Changeux; D Servent; A Ménez
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

3.  Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor.

Authors:  Carole Fruchart-Gaillard; Bernard Gilquin; Stephanie Antil-Delbeke; Nicolas Le Novère; Toru Tamiya; Pierre-Jean Corringer; Jean-Pierre Changeux; André Ménez; Denis Servent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor.

Authors:  Gilles Mourier; Sébastien Dutertre; Carole Fruchart-Gaillard; André Ménez; Denis Servent
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

5.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 6.  Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on.

Authors:  Selvanayagam Nirthanan; Matthew C E Gwee
Journal:  J Pharmacol Sci       Date:  2004-01       Impact factor: 3.337

7.  Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops.

Authors:  Anu Kukkonen; Mikael Peräkylä; Karl E O Akerman; Johnny Näsman
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

Review 8.  Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors.

Authors:  E Karlsson; M Jolkkonen; E Mulugeta; P Onali; A Adem
Journal:  Biochimie       Date:  2000 Sep-Oct       Impact factor: 4.079

  8 in total
  1 in total

1.  Specific membrane binding of neurotoxin II can facilitate its delivery to acetylcholine receptor.

Authors:  Dmitry M Lesovoy; Eduard V Bocharov; Ekaterina N Lyukmanova; Yurij A Kosinsky; Mikhail A Shulepko; Dmitry A Dolgikh; Mikhail P Kirpichnikov; Roman G Efremov; Alexander S Arseniev
Journal:  Biophys J       Date:  2009-10-07       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.